SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-20-000575
Filing Date
2020-01-24
Accepted
2020-01-24 16:30:22
Documents
1
Period of Report
2020-01-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-47552.html 4  
1 PRIMARY DOCUMENT marketforms-47552.xml 4 3150
  Complete submission text file 0001214659-20-000575.txt   4655
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Issuer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HUMANIGEN, INC. 1000 MARINA BOULEVARD, SUITE 250 BRISBANE CA 94005-1878
Business Address
Boehm Rainer J. (Reporting) CIK: 0001732381 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35798 | Film No.: 20545868